Source: Medicines Authority (MT) Revision Year: 2018 Publisher: Actavis Group PTC ehf, Reykjavikurvegi 76-78, 220 Hafnarfjordur, Iceland
Brieka 25 mg capsules, hard.
Brieka 50 mg capsules, hard.
Brieka 75 mg capsules, hard.
Brieka 100 mg capsules, hard.
Brieka 150 mg capsules, hard.
Brieka 200 mg capsules, hard.
Brieka 225 mg capsules, hard.
Brieka 300 mg capsules, hard.
| Pharmaceutical Form |
|---|
|
Capsule, hard. The 25 mg capsule is white, size 4 (14.5 mm), marked "PGB 25" on the body with black ink. The 50 mg capsule is white, size 3 (16 mm), marked "PGB 50" on the body with black ink. The body is also marked with a black circular line. The 75 mg capsule is white and orange, size 4 (14.5 mm), marked "PGB 75" on the body with black ink. The 100 mg capsule is orange, size 3 (16 mm), marked "PGB 100" on the body with black ink. The 150 mg capsule is white, size 2 (18 mm), marked "PGB 150" on the body with black ink. The 200 mg capsule is light orange, size 1 (19.5 mm), marked "PGB 200" on the body with black ink. The 225 mg capsule is white and light orange, size 1 (19.5 mm), marked "PGB 225" on the body with black ink. The 300 mg capsule is white and orange, size 0 (21.5 mm), marked "PGB 300" on the body with black ink. |
Each capsule, hard contains 25 mg of pregabalin.
Each capsule, hard contains 50 mg of pregabalin.
Each capsule, hard contains 75 mg of pregabalin.
Each capsule, hard contains 100 mg of pregabalin.
Each capsule, hard contains 150 mg of pregabalin.
Each capsule, hard contains 200 mg of pregabalin.
Each capsule, hard contains 225 mg of pregabalin.
Each capsule, hard contains 300 mg of pregabalin.
For the full list of excipients, see section 6.1.
| Active Ingredient |
|---|
|
Pregabalin binds to an auxiliary subunit (α2-δ protein) of voltage-gated calcium channels in the central nervous system. |
| List of Excipients |
|---|
|
Capsules content: Mannitol Capsules shell: Gelatin Only applicable for 75 mg, 100 mg, 200 mg, 225 mg and 300 mg Red iron oxide (E172) Printing Ink: Shellac |
25 mg:
Aluminium/PVC blisters containing 14, 21, 30, 56, 60, 84, 90 or 100 capsules, hard.
HDPE bottle with LDPE lid or PP screw cap containing 100 capsules, hard.
50 mg:
Aluminium/PVC blisters containing 14, 21, 30, 56, 60, 84, 90 or 100 capsules, hard.
HDPE bottle with LDPE lid or PP screw cap containing 100 capsules, hard.
75 mg:
Aluminium/PVC blisters containing 14, 21, 30, 56, 60, 84, 90 or 100 capsules, hard.
HDPE bottle with LDPE lid or PP screw cap containing 100 capsules, hard.
100 mg:
Aluminium/PVC blisters containing 14, 21, 30, 56, 60, 84, 90 or 100 capsules, hard.
HDPE bottle with LDPE lid or PP screw cap containing 100 capsules, hard.
150 mg:
Aluminium/PVC blisters containing 14, 30, 56, 60 or 100 capsules, hard.
HDPE bottle with LDPE lid or PP screw cap containing 100 capsules, hard.
200 mg:
Aluminium/PVC blisters containing 14, 21, 30, 56, 60, 84, 90 or 100 capsules, hard.
HDPE bottle with LDPE lid or PP screw cap containing 100 capsules, hard.
225 mg:
Aluminium/PVC blisters containing 14, 21, 30, 56, 60, 84, 90 or 100 capsules, hard.
HDPE bottle with LDPE lid or PP screw cap containing 100 capsules, hard.
300 mg:
Aluminium/PVC blisters containing 14, 56, 60 or 100 capsules, hard.
HDPE bottle with LDPE lid or PP screw cap containing 100 capsules, hard.
Not all pack sizes may be marketed.
Actavis Group PTC ehf, Reykjavikurvegi 76-78, 220 Hafnarfjordur, Iceland
Brieka, 25 mg, Capsule, hard MA628/13301
Brieka, 50 mg, Capsule, hard MA628/13302
Brieka, 75 mg, Capsule, hard MA628/13303
Brieka, 100 mg, Capsule, hard MA628/13304
Brieka, 150 mg, Capsule, hard MA628/13305
Brieka, 200 mg, Capsule, hard MA628/13306
Brieka, 225 mg, Capsule, hard MA628/13307
Brieka, 300 mg, Capsule, hard MA628/13308
22nd June 2015
| Drug | Countries | |
|---|---|---|
| BRIEKA | Estonia, Ireland, Lithuania, Singapore |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.